Effects of oxygen ozone therapy on cardiac function in a patient with a prior myocardial infarction


https://doi.org/10.4081/ozone.2017.6745
0
0
0
0
Smart Citations
0
0
0
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Authors

  • Sergio Pandolfi
    sergiopandolfis2@gmail.com
    Scientific Society of Oxygen-Ozone Therapy, Gorle (BG); Villa Mafalda Nursing Home, Rome, Italy.
  • Angelo Zammitti Scientific Society of Oxygen-Ozone Therapy, Gorle (BG); Villa Mafalda Nursing Home, Rome, Italy.
  • Marianno Franzini Scientific Society of Oxygen-Ozone Therapy, Gorle (BG); Department of Internal Medicine and Medical Therapy, Master in Oxygen-Ozone Therapy, University of Pavia, Italy.
  • Vincenzo Simonetti Scientific Society of Oxygen-Ozone Therapy, Gorle (BG); Kaos non-profit Association, Caselle Torinese (TO), Italy.
  • William Liboni Un Passo Insieme Onlus Foundation, Valdellatorre (TO), Italy.
  • Luigi Valdenassi Scientific Society of Oxygen-Ozone Therapy, Gorle (BG); Department of Internal Medicine and Medical Therapy, Master in Oxygen-Ozone Therapy, University of Pavia, Italy.
  • Filippo Molinari Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy.
Oxygen-ozone therapy has been piloted in Italy patients with ischemic heart disease or suffering from myocardial infarction since 1991. Over time, it has been observed that ozone exerts a significant anti-inflammatory and rheological activity: ozone activates the redox system, lowers the pro-inflammatory cytokines16β, TNFα, modulates the NF-KB system, reduces platelet aggregation, and stimulates the release of growth factors. It is because of these characteristics that oxygen-ozone therapy is used in the prevention and treatment of ischemic heart disease and for post-infarction rehabilitation. The case study – a critically ill patient aged 76 with acute myocardial infarction (AMI), suffering from ischemic heart disease and heart attacks, high blood pressure, renal failure, ischemic vascular pluri-infarct CNS disease, Parkinsonism, stroke, neurological bladder disease and debilitating inguinal hernia – after a year and a half of AMI with infusions of autologous blood treated with ozone (GAE), recovered the left ventricular ejection fraction from 33 to 50% and underwent a successful inguinal hernia operation. It appears evident that oxygen ozone therapy using GAE protect the hearts of patients suffering from ischemic heart disease, and is useful during the acute phase of infarctions, as well as for rehabilitating patients who have had an AMI with stenting.